简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-06-09 11:50 Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy
2026-06-09 11:46 Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy
2026-06-08 11:35 Tsuno Rice Fine Chemicals: Comparative Absorption Study of Rice Bran-Derived “Rice Magnesium” Reveals New Insights into Its Gradual, Sustained Absorption Profile
2026-06-05 10:33 New Evidence Offers Hope for Ketogenic Therapy in Treatment of Anorexia Nervosa
2026-06-03 12:04 BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
2026-06-01 13:19 BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
2026-06-01 11:06 SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
2026-06-01 11:01 Rubedo’s RLS-1496 Reduces Actinic Keratosis Pre-Cancerous Skin Lesions by 46% at Four Weeks with Minimal Irritation in Preliminary Results of Phase 1b/2a Study
2026-05-29 10:27 BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026
2026-05-28 11:37 Parse Biosciences and bit.bio Announce Landmark Alliance
2026-05-28 11:20 Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)
2026-05-27 18:02 Mevion Medical Systems and Tam Anh General Hospital Partner to Bring Advanced Proton Therapy to Vietnam
2026-05-27 17:14 Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure
2026-05-25 11:50 Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly
2026-05-25 11:45 Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
2026-05-25 11:35 BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
2026-05-25 11:22 Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
2026-05-25 11:20 Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis
2026-05-22 09:10 Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
2026-05-22 09:08 SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

Business Wire Weibo

Press Releases

Latest Releases